Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).
Ingvild FarnesDyre KleiveCaroline S VerbekeLars AabakkenAart Issa-EpeMilada Cvancarova SmåstuenBjarte V FosbySvein DuelandPål-Dag LineKnut J LaboriPublished in: BJS open (2024)
Resection rates and survival in patients with borderline resectable pancreatic cancer and locally advanced pancreatic cancer treated at a high-volume centre in a universal healthcare system compare well with those treated at international expert centres.Registration number: NCT04423731 (http://www.clinicaltrials.gov).